Cannabis Hemp

Industrial Hemp is Helping to Grow the Legal Cannabis Market

NEW YORKAugust 13, 2018 /PRNewswire/ —

According to a research report by Mordor Intelligence, the global cannabis market was valued at USD 7.7 Billion in 2016 and is expected to reach USD 65 Billion by 2023 while registering a healthy CAGR of 37% during the forecast period. The strong growth is attributed to the continued legalization of cannabis use for medical and recreational purposes across various states in the U.S. Currently, North America accounts for more than 95% of the global cannabis market, with the U.S. itself alone making up more than 90% of the North American and the global market. Inc. (OTC: CIIX), CV Sciences Inc. (OTC: CVSI), Medicine Man Technologies Inc. (OTC: MDCL), Freedom Leaf Inc. (OTC: FRLF), PotNetwork Holdings Inc. (OTC: POTN)

A major portion of the legal cannabis market is the industrial hemp segment. According to Grand View Research, the global industrial hemp market size was estimated at USD 3.9 Billion in 2017 and will be expanding at a CAGR of 14.0% over the forecast period of 2018 – 2025. “The political link between industrial hemp and marijuana has resulted in several restrictions on hemp cultivation, processing, distribution, and consumption across the globe. However, increasing liberalization and legalization of hemp cultivation with THC content not more than 0.3 in several countries is expected to have a positive impact on market growth,” the research states. Inc. (OTCQB: CIIX) just earlier today announced breaking news that, “its wholly owned subsidiary, Inc. will hold a seminar at its flagship retail store, Chinese Wellness Center, located at 227 West Valley Blvd. #208-B in San Gabriel, CA., covering “The Health Benefits of Hemp Oil,” featuring Chinese Medicine Practitioner Amin Wang. Inc., a wholly owned subsidiary of, Inc., is responsible for the online and retail sales of hemp-based health products in the United States and has been building awareness for its “Opt Hemp” brand among Chinese consumers in the U.S. since its establishment in April 2017. In June 2017, the Company officially opened its first retail location known as Chinese Wellness Center and launched its website Chinese Wellness Center is located in the predominantly Chinese community of San Gabriel, California, directly adjacent to the Company’s headquarters. In July 2017, the Company established a club-style Hemp Education Center to provide community-centered education and outreach about the potential benefits of hemp, which has roots in ancient Chinese medicine, and hemp-derived CBD, which is believed by many to have positive balancing effects on the mind and body.

The Hemp Education Center at Chinese Wellness Center hosts regular events designed to cement its status as a resource for the local Chinese community. The August 18th Seminar will be the fourth seminar for 2018. ‘We are pleased with the positive feedback we receive from customers regarding both our educational events and our amazing hemp-based products,’ says Nina Wang, General Manager of Inc.

Most recently, Inc. kicked off a print and radio ad campaign beginning with placements in the World Journal in Los Angeles and a three-month radio campaign airing on Chinese-language radio in New York, NY. To promote seminar attendance, the Company is also conducting a call center awareness campaign, which will reach out to consumers living in the predominantly Chinese residential areas of the San Gabriel Valley and surrounding areas, home to approximately 525,000 Asian-Americans, with Chinese being the largest group.

In addition to Inc.’s established retail store, Chinese Wellness Center, and its website , its OptHemp products can also be purchased at over 200 retail shops in the Los Angeles area.”

CV Sciences Inc. (OTCQB: CVSI) operates two distinct business segments: a drug development division focused on developing and commercializing novel therapeutics utilizing synthetic CBD; and, a consumer product division focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors. The Company recently announced that its sales for Q2 2018 were USD 12.3 Million, demonstrating the Company’s continued organic expansion into all sales channels including the natural product retail, wholesale and direct-to-consumer channels. This is a 53% sequential quarterly increase from USD 8.1 Million reported for Q1 2018. “CV Sciences delivered strong financial results for the second quarter of 2018, including our second consecutive quarter of profitability. We also reported record key performance metrics that include triple-digit year-over-year revenue growth and double-digit sales growth on a sequential quarterly comparison,” stated Joseph Dowling, Chief Executive Officer of CV Sciences.

Medicine Man Technologies Inc. (OTCQB: MDCL), established in March 2014, secured its first client/licensee in April 2014. The Company has recently reported its financial results for the quarter ended June 30th, 2018. During the three months ending June 30th, 2018, the Company generated revenues of USD 1,417,687, an increase of 535,334 or approximately 61%, compared to revenues of USD 882,353 in the three months ending June 30th, 2017. Total revenues include Cultivation Max revenue of USD 723,698, consulting and licensing fees of USD 287,062, product sales net revenue of USD 232,565, related party product sales net revenue of USD 148,135, and reimbursements of USD 20,099. The increase in revenues is primarily attributable to revenue related to Cultivation Max, which began support for several operators during mid to late fiscal 2017. “We continue to demonstrate strong revenue growth as we conclude our second consecutive profitable quarter,” Brett Roper, Medicine Man Technologies’ co-founder, and Chief Executive Officer stated. “After considerable preparation, we are pleased to be applying to move the Company to QX status on the OTC markets, which we expect to finalize during the third quarter of 2018. This up-listing will, among other benefits, allow us to take full advantage of regulations in Colorado that allow fully reporting public companies to hold ownership of plant touching licenses in the state.”

Freedom Leaf Inc. (OTCQB: FRLF) is a group of diversified, international, vertically-integrated hemp businesses concentrating on health, wellness, and education as well as cannabis media companies. Freedom Leaf has recently announced that it has consummated a 100% acquisition of Tierra Science Global LLC, a company specializing in health supplements supporting peak bio-energy levels in humans which are currently distributed via highly motivated direct sales teams and well-established affiliate programs in EuropeAsia and the United States. Freedom Leaf will take the brand and potential revenues one significant step further by manufacturing a number of unique Full Spectrum Hemp/CBD oil products including two skin serums by renown Beverly Hills Anti-Aging Practitioner, Dr. Naina Sachdev(NAINAMD), who most recently served as the Ambassador for Procter & Gamble Olay’s Regenerist skin care line internationally is also ABAARM certified Medical Director at NAINAMD™ Anti-Aging & Regenerative Clinic in Beverly Hills, CA and affiliate clinics with her current international client base from Beverly Hills to Dubai. Manufacturing will be done by Freedom Leaf’s wholly-owned subsidiary, IRIE CBD Medicinals and will include the launch of an assertive affiliate marketing campaign to market and distribute Tierra branded products such as pain cream, calming tinctures, honey sticks and more to meet ever increasing demand for these products worldwide

PotNetwork Holdings Inc. (OTC: POTN) is a publicly traded company that acts as a holding company for its subsidiaries, First Capital Venture Co., the owner of Diamond CBD Inc., the maker of Diamond CBD oils. PotNetwork recently announced that its wholly owned subsidiary, Diamond CBD Inc., successfully displayed the Company’s full product line including its newest products at the 56th ASD Market Week trade show at the Las Vegas Convention Center, July 29-August 1st, gaining over 400 new orders in the 3 days of the show. Historically, trade shows, such as the ASD Market Week shows, have been highly successful events for Diamond CBD generating both valuable publicity and record sales. ASD Market Week is held twice per year in Las Vegas and has been called the wholesale buying event that can’t be missed for any small to large sized retail, distribution, or importing business. The show is attended each year by 45,000 buyers from over 90 countries. Of those attendees, 98% have major purchasing power such that the average buyer spends USD 82,500 per show, equating to USD 2.8 Billion annually across hundreds of product categories. 88% of these buyers are domestic and 12% international.  With products in all 50 states and a growing international brand awareness, Diamond CBD is a growing industry leader with proprietary premium products that contain a broad range of cannabinoids, natural hemp derivatives and hemp extracts. Diamond CBD focuses on the research, development, and multinational marketing of premium hemp extracts that contain a broad range of cannabinoids and natural hemp derivatives.

Subscribe Now! Watch us report LIVE

Follow us on Twitter for real time Financial News Updates:

Follow and talk to us on Instagram:

Facebook Like Us to receive live feeds:

About, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, creates 100% unique original content. also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on  (the ‘Site’) is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content),, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. receives fees for producing and presenting high quality and sophisticated content on along with other financial news PR media services. does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For Inc. financial news dissemination and PR services, expects to be compensated three thousand dollars by the company. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. will always disclose any compensation in securities or cash payments for financial news PR advertising. has signed a two-year agreement with Inc. for one hundred thousand restricted common shares for continued financial news dissemination and PR services. does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security., members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: .

For further information:




Will Low-THC Cannabis Be The Next Big Trend in Cannabis?
LA’s ‘Pot Czar’ on Risks of Buying From Illegal Dispensaries
Early data suggest medicinal cannabis could treat prostate cancer

Leave Your Reply